| Literature DB >> 28879548 |
Keiko Aota1, Tomoko Yamanoi2, Koichi Kani2, Masayuki Azuma2.
Abstract
Cepharanthine, a biscolaurine alkaloid isolated from the plant Stephania cephalantha Hayata, has been reported to have potent anti-inflammatory properties. Here, we investigated the effects of cepharanthine on the expression of CXCL10 (a CXC chemokine induced by interferon-gamma [IFN-γ] that has been observed in a wide variety of chronic inflammatory disorders and autoimmune conditions) in IFN-γ-treated human salivary gland cell lines. We observed that IFN-γ-induced CXCL10 production in NS-SV-DC cells (a human salivary gland ductal cell line), but not in NS-SV-AC cells (a human salivary gland acinar cell line). Cepharanthine inhibited the IFN-γ-induced CXCL10 production in NS-SV-DC cells. A Western blot analysis showed that cepharanthine prevented the phosphorylation of JAK2 and STAT1, but did not interfere with the NF-κB pathway. Moreover, cepharanthine inhibited the IFN-γ-mediated chemotaxis of Jurkat T cells. These results suggest that cepharanthine suppresses IFN-γ-induced CXCL10 production via the inhibition of the JAK2/STAT1 signaling pathway in human salivary gland ductal cells. Our findings also indicate that cepharanthine could inhibit the chemotaxis of Jurkat T cells by reducing CXCL10 production.Entities:
Keywords: CXCL10; IFN-γ; JAK/STAT1 signaling; cepharanthine; primary Sjögren’s syndrome; salivary gland ductal cells
Mesh:
Substances:
Year: 2018 PMID: 28879548 DOI: 10.1007/s10753-017-0662-x
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092